Part of Thermo Fisher Scientific

HOME | PRODUCTS | COMPANY | LIBRARY | ORDER | LINKS

Press Release

HyClone Breaks Ground for New World Class Manufacturing Facility

Cramlington, UK (May 26, 2003)-
In a groundbreaking ceremony attended by the Perbio Board, local dignitaries and construction company officials, HyClone marked the next phase in the expansion of their global manufacturing capabilities. A state-of-the-art, 5,000 SqM facility representing an investment of US$11M (GBP7.4M) will be constructed at the UK site located in Cramlington, England.

Construction will occur over two phases, providing manufacturing for sterile liquids, BioProcess Containers (BPCs) and Dry Powdered Media (DPM). Completion is scheduled for March 2004.

The initial phase includes the construction of a 3,000 SqM two-story facility incorporating manufacturing clean rooms, facility support and office space. The clean rooms, totalling 2,840 SqM, include:

The second phase will incorporate the conversion of the existing 2,000 SqM facility into warehouse, logistics and additional office space.

Marc Strijbos, VP Perbio Science Europe, said of the investment, “The new build is an exciting development in HyClone's support of the Biopharmaceutical Industries. It combines the HyNetics stateof- the-art liquid handling system with our CX5-14 advanced film technology, to produce true ADCF segregated liquid handling from formulation to packaging.”

For further information, contact:
Marc Strijbos, VP Perbio Science Europe, at marc.strijbos@perbio.com, phone: +32 53 83 44 04
Sabine De Beuf, Marketing Manager, at sabine.de.beuf@perbio.com, phone: +32 53 83 44

HyClone is a global manufacturer of serum, liquid and powdered media, sterile liquids and sterile liquid handling systems to support research and production of biopharmaceuticals. HyClone is owned by Perbio Science. For more information about HyClone, visit the web site at www.hyclone.com.

Perbio Science AB is an international biotech company based in Sweden whose customers are found within research institutions, pharmaceutical companies and diagnostics manufacturers. The majority of the company’s operations take place in the USA. Perbio Science develops products within the areas of Bioresearch, Cell Culture and Medical Devices. The group has 1,155 employees with offices in Sweden, USA and a number of other countries. The head office is in Helsingborg, Sweden. More information regarding Perbio Science can be found at www.perbio.com.

Click Here for a printable PDF version of this Press Release.